◂ Previous issue Next issue ▸ Archive Cover PDF   

Volume 14 (17); 2023

Research Papers

Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis
Lingbin Meng, Biwei Cao, Rui Ji, Dung-Tsa Chen, Damian A. Laber, Michael Shafique
J. Cancer 2023; 14(17): 3169-3175. doi:10.7150/jca.87052
Abstract Full text PDF PubMed PMC

High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis
Yufeng Li, Yajun Li, Ruolan Zeng, Yizi He, Liang Liang, Lijia Ou, Chang Su, Hui Zhou, Ling Xiao
J. Cancer 2023; 14(17): 3182-3190. doi:10.7150/jca.85756
Abstract Full text PDF PubMed PMC

Gut microbiota deficiency ameliorates multiple myeloma and myeloma-related bone disease by Th17 cells in mice models
Jia Liu, Fang Xie, Zhi-gang Yi, Tao Ma, Wen-ting Tie, Yan-hong Li, Jun Bai, Lian-sheng Zhang
J. Cancer 2023; 14(17): 3191-3202. doi:10.7150/jca.88799
Abstract Full text PDF PubMed PMC

Distant Metastasis is the Dominant Cause of Treatment Failure after Lateral Lymph Node Dissection in Patients with Lateral Lymph Node Metastasis: Results of the Large Multicenter Lateral Node Study in China
Kan Li, Feng Wang, Yujuan Jiang, Gong Hong, Zijin Li, Jianwei Liang, Weinan Wu, Wei Xing, Qian Liu
J. Cancer 2023; 14(17): 3227-3237. doi:10.7150/jca.88009
Abstract Full text PDF PubMed PMC

CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas
Zhiqiang Wu, Liyuan Deng, Jin Tao, Yuhai Lu, Xiaofei Zeng, Weikun Jia, Hu Chen
J. Cancer 2023; 14(17): 3238-3247. doi:10.7150/jca.87983
Abstract Full text PDF PubMed PMC

Activation of assembly factor for spindle microtubules triggers progression of renal cell carcinoma via Wnt3a pathway
Zhijun Cao, Yu Li, Chen Xu, Zhiyu Zhang, Zhenfan Wang, Zheng Ma, Pengwei Xu, Xiaofei Sun, Xuefeng He, Jianglei Zhang, Hao Jiang, Gang Li
J. Cancer 2023; 14(17): 3248-3257. doi:10.7150/jca.88063
Abstract Full text PDF PubMed PMC

Adverse Event Profile Differences between Trastuzumab Emtansine and Trastuzumab Deruxtecan: A Real-world, Pharmacovigilance Study
Fen Liu, Guisen Yin, Shuyi Xue, Faisal UL Rehman, Dehua Liao, Yong Pan
J. Cancer 2023; 14(17): 3275-3284. doi:10.7150/jca.86746
Abstract Full text PDF PubMed PMC

Molecular Mechanism of Vitamin D Receptor Modulating Wnt/β-catenin Signaling Pathway in Gastric Cancer
Ying Zhang, Yan Li, Yuzheng Wei, Lei Cong
J. Cancer 2023; 14(17): 3285-3294. doi:10.7150/jca.81034
Abstract Full text PDF PubMed PMC

Ablation of the GDP-fucose transporter suppresses lung cancer cell proliferation and migration by reducing expression of PD-L1
Yingshu Zhang, Nianzhu Zhang, Wanli Song, Sabiha Yousuf, Wenzhe Li
J. Cancer 2023; 14(17): 3295-3308. doi:10.7150/jca.84652
Abstract Full text PDF PubMed PMC

Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
Sunshun Yan, Chunbo Ma, Feng Zhou, Hailun Zheng, Lehe Yang, Zhongxiang Xiao, Jiandong Zhu, Haiyang Zhao, Chengguang Zhao, Xiaoling Xu
J. Cancer 2023; 14(17): 3309-3320. doi:10.7150/jca.86544
Abstract Full text PDF PubMed PMC

High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma
Rui Han, Youhong Guan, Min Tang, Min Li, Binbin Zhang, Guanghe Fei, Sijing Zhou, Ran Wang
J. Cancer 2023; 14(17): 3321-3334. doi:10.7150/jca.88635
Abstract Full text PDF PubMed PMC

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
Gang Liu, Feifei Li, Yuntian Ge, Yaxing Shi, Fang Ren, Liancheng Zhu
J. Cancer 2023; 14(17): 3335-3350. doi:10.7150/jca.88467
Abstract Full text PDF PubMed PMC

Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma
Ankang Zhu, Yan Zong, Shuai Wei, Yinuo Li, Yan Fan, Shaodong Liu, Xingcai Gao
J. Cancer 2023; 14(17): 3351-3367. doi:10.7150/jca.88650
Abstract Full text PDF PubMed PMC

Development of A Nomogram for Progression-free Survival in Patients with Stage II/T3N0 Nasopharyngeal Carcinoma to Explore Different Treatment Modalities
Chang Yan, Rong Zhao, Kai-Hua Chen, Biao-You Chen, Chao-Jun Zhang, Xi Chen, Wan-Wan Meng, Lin Lai, Song Qu, Xiao-Dong Zhu
J. Cancer 2023; 14(17): 3368-3377. doi:10.7150/jca.87901
Abstract Full text PDF PubMed PMC

Reviews

Inguinal Lymph Node Metastasis as Sole Manifestation of Ovarian / Fallopian Tube Cancer: a Review of the Literature
Sofoklis Stavros, Anastasios Potiris, Nikolaos Machairiotis, Alexandros Fotiou, Pavlos Zarogoulidis, Eirini Drakaki, Theodoros Karampitsakos, Christos Koratzanis, Spyridon Michalopoulos, Dionysios Vrachnis, Panagoula Oikonomou, Nikolaou Christina, Charalampos Charalampidis, Stamatios Petousis, Aris Ioannidis, Dimitris Matthaios, Ekaterini Domali, Peter Drakakis
J. Cancer 2023; 14(17): 3176-3181. doi:10.7150/jca.88863
Abstract Full text PDF PubMed PMC

Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma
Bai Ding, Yinghui Song, Sulai Liu, Chuang Peng, Yujing Zhang
J. Cancer 2023; 14(17): 3203-3213. doi:10.7150/jca.86967
Abstract Full text PDF PubMed PMC

The oncogenic potential of Rab-like protein 1A (RBEL1A) GTPase: The first review of RBEL1A research with future research directions and challenges
Ki Lui, Ying Huang, M. Saeed Sheikh, Kwok-Kuen Cheung, Wing Yip Tam, Keng-Ting Sun, Ka Ming Cheng, Winnie Wing Man Ng, Anthony Wai-Keung Loh
J. Cancer 2023; 14(17): 3214-3226. doi:10.7150/jca.84267
Abstract Full text PDF PubMed PMC

SRY-box transcription factor 21 antisense divergent transcript 1: Regulatory roles and clinical significance in neoplastic conditions and Alzheimer's Disease
Ling Lei, Guangxi Peng, Hongliang Luo, Wugen Li
J. Cancer 2023; 14(17): 3258-3274. doi:10.7150/jca.89619
Abstract Full text PDF PubMed PMC

©2024 Ivyspring International Publisher. Terms of use